<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03868956</url>
  </required_header>
  <id_info>
    <org_study_id>2018-CHITS-04</org_study_id>
    <secondary_id>2019-A00136-51</secondary_id>
    <nct_id>NCT03868956</nct_id>
  </id_info>
  <brief_title>Diagnosis Exclusion of Recurrent Deep Vein Thrombosis of the Lower Limbs</brief_title>
  <acronym>ULTREC</acronym>
  <official_title>Safety of a Management Strategy Based on Colour Doppler ULTrasound and D-Dimer Testing for the Diagnosis Exclusion of RECurrent Deep Vein Thrombosis of the Lower Limbs. The ULTREC Project</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Centre Hospitalier Universitaire de Saint Etienne</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Investigation network on venous thrombo-embolism</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose is to assess the safety of a management strategy based on colour doppler
      ultrasound (CDUS) and D-Dimer test results for the diagnosis exclusion of recurrent deep vein
      thrombosis (DVT) of the lower limbs.

      DVT recurrence requires using anticoagulant treatment to prevent thrombosis progression.
      Given an increased bleeding risk with prolonged treatment, an accurate diagnosis for
      recurrence is needed. However, the diagnosis of a new thrombosis in a previously involved leg
      is difficult. Imaging modalities and criteria that are currently used for the diagnosis may
      be equivocal and unable to discriminate between an old clot and a new one recently developed
      at the same site. An increase in vein diameter after vein compression by the ultrasound probe
      was suggested as a diagnostic criterion for a new DVT. This method has many limitations in
      clinical practice, mainly a lack of availability of a previous measurement and a poor
      inter-observer agreement.

      Colour Doppler ultrasound enables to study both the thrombus and the blood flow
      characteristics that might help to overcome these limitations. CDUS is a well-known method
      for the diagnosis of vascular diseases and is used in every day clinical practice for the
      diagnosis of a first DVT and DVT recurrence but CDUS has never been assessed for DVT
      recurrence in a study. The diagnosis of DVT recurrence may be easily established using the
      same criteria as for a first DVT episode. Our hypothesis is that CDUS associated with D-Dimer
      can safely rule out the diagnosis of DVT recurrence while maintaining a good specificity.

      The strategy consists in performing first a CDUS that helps to classify patients as having
      (positive CDUS) or not having (negative CDUS) a new thrombosis. In the case of an equivocal
      CDUS, a D-Dimer test is performed. If the D-dimer is normal, the diagnosis of DVT recurrence
      is ruled out and the patient is not treated. If the D-dimer is abnormal, the diagnosis cannot
      be excluded nor confirmed and a second CDUS is performed on D7±2. Meanwhile, patients are not
      treated by anticoagulants. An unchanged CDUS on D7±2 qualifies patients as free from a new
      DVT and they are not treated. Conversely a change in CDUS qualifies patients as having a new
      DVT which requires anticoagulant treatment.

      All patients have a 3-month follow-up for the assessment of potential venous thromboembolic
      events.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Venous thromboembolism (VTE) recurrence is a common situation after stopping anticoagulant
      treatment. This recurrence requires extended anticoagulant therapy to prevent thrombosis
      progression and embolization, but given an increased bleeding risk with prolonged treatment,
      an accurate diagnosis for VTE recurrence is needed.

      Unfortunately, there is no reference standard for the diagnosis of deep vein thrombosis (DVT)
      recurrence and objective and accurate diagnostic methods are lacking. Clinical assessment
      does not allow discriminating between a previous and a recent thrombosis and there is no
      clinical prediction rule specific to the suspicion of DVT recurrence. D-dimer assays alone
      may not be able to safely exclude the diagnosis of DVT recurrence, and they have not been
      sufficiently validated in combination with clinical probability. The same holds for imaging
      modalities because normalisation rate after proximal DVT is low and a &quot;residual thrombosis&quot;
      may make difficult the diagnosis of a new thrombosis episode at the same site. Phlebography
      is non-diagnostic in 33% of cases. CT-venography has never been evaluated and MRI direct
      thrombus imaging (MRDTI) although very promising is still under evaluation.

      As compression ultrasound (CUS) may be equivocal due to a residual thrombosis, a comparison
      to baseline measurements of residual vein diameter after full compression at the common
      femoral and the popliteal vein segments in cross-sectional plane has been suggested with an
      increase in diameter superior to 2 or 4 mm as a diagnosis criterion. This method has many
      major limitations related to: 1/the need for a previous measurement almost never available in
      practice, 2/ the potential for recurrence at a different site than that previously measured,
      3/ a poor inter-observer agreement or at least inconsistent inter-observer variability
      between studies, 4/ small sample sizes in diagnostic accuracy and in diagnostic management
      studies and 5/ lack of external validation. Due to these limitations, recurrent ipsilateral
      DVT is mainly diagnosed by CUS when it occurs in a new or a normalised vein segment.

      Colour Doppler ultrasound (CDUS) enables to study both the thrombus and the blood flow
      characteristics that might help to overcome the limitations of CUS and diameter measurements.
      Although CDUS has never been assessed for DVT recurrence in a study, it is used in every day
      clinical practice and seems very helpful. The diagnosis may be easily established using the
      same CDUS criteria as for a first DVT episode. Our hypothesis is that CDUS associated with
      D-Dimer can safely exclude the diagnosis of recurrent DVT while maintaining a good
      specificity.

      The strategy consists in performing first a CDUS that helps to classify patients as having
      (positive CDUS) or not having (negative CDUS) a new thrombosis. In the case of an equivocal
      (non-diagnostic) CDUS, a D-Dimer test is performed followed by repeat CDUS on D7±2 if D-dimer
      test result is abnormal. Meanwhile, patients are not treated by anticoagulants. A negative
      D-dimer test or an unchanged CDUS on D7±2 qualifies patients as free from a new DVT.
      Conversely a change in CDUS qualifies patients as having a new DVT. Only patients with a new
      DVT are treated. All patients have a 3-month follow-up for the assessment of venous
      thromboembolic and bleeding events by an independent adjudication committee.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 17, 2020</start_date>
  <completion_date type="Anticipated">January 17, 2023</completion_date>
  <primary_completion_date type="Anticipated">January 17, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adjudicated symptomatic venous thromboembolic events</measure>
    <time_frame>3 months</time_frame>
    <description>Rate of adjudicated symptomatic venous thromboembolic (VTE) events among patients not treated by anticoagulants according to the diagnostic strategy
The criteria for recurrent VTE include:
objectively confirmed pulmonary embolism (PE) by either CT pulmonary angiography or ventilation-perfusion scan,
death due to PE,
and recurrent DVT of the leg Death, cause of death, VTE comprising isolated proximal or distal DVT and PE (with or without DVT), will be adjudicated by an independent clinical event committee blinded to the classification of the diagnostic strategy.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prevalence of deep vein thrombosis recurrence</measure>
    <time_frame>Up to 3 months</time_frame>
    <description>Proportion of patients with a new DVT among all patients included based on the results of the diagnostic tests used in the strategy and on the occurrence of VTE events during follow-up in patients untreated</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients tested negative</measure>
    <time_frame>A day if the diagnostic strategy is conclusive (either positive or negative) at day 0, or 7 days if it is inconclusive</time_frame>
    <description>Proportion of patients tested negative by the strategy for DVT recurrence among all patients included</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of complete patients</measure>
    <time_frame>3 months</time_frame>
    <description>Proportion of patients who completed the strategy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bleeding complication occurrence</measure>
    <time_frame>3 months</time_frame>
    <description>The occurrence of bleeding complications will be assessed among all patients included during a 3-month follow-up period. The severity of these complications will be adjudicated by the independent clinical event committee according to the International Society on Thrombosis and Haemostasis classification criteria.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">465</enrollment>
  <condition>Deep Vein Thrombosis</condition>
  <arm_group>
    <arm_group_label>Diagnostic strategy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Colour doppler ultrasound (CDUS) with or without D-dimer test to rule-in or rule-out deep vein thrombosis recurrence</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Colour doppler ultrasound with or without D-dimer test</intervention_name>
    <description>Positive CDUS: anticoagulant treatment
Negative CDUS: no anticoagulant treatment
Non diagnostic CDUS : reference to routine D-dimer test
Negative test : no anticoagulant treatment
Positive test : second CDUS 7 days (±2) after first one
No change in CDUS : no anticoagulant treatment
Change in CDUS : anticoagulant treatment</description>
    <arm_group_label>Diagnostic strategy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt;= 18 years

          -  Known history of objectively documented deep vein thrombosis of the lower limb (with
             or without pulmonary embolism)

          -  Out-patients referred for clinically suspected acute recurrent ipsilateral DVT of the
             lower limb i.e. the occurrence of new symptoms and signs of DVT or the increase of
             symptoms and signs in patients with post-thrombotic syndrome

          -  Patients covered by social security or equivalent regimen

          -  Signed and dated informed consent

        Exclusion Criteria:

          -  Known current pregnancy

          -  Any condition, which, in the opinion of the investigator may prevent him from
             performing the colour doppler ultrasound test (plaster cast, inaccessible vein segment
             after abdominal or pelvic surgery, or other causes that may lead to a technically
             inadequate CDUS)

          -  Delay from onset of symptoms to inclusion of more than 10 days

          -  Therapeutic anticoagulation for more than 48 hours in the two days prior to consent

          -  Prophylactic anticoagulation for more than 48 hours in the two days prior to consent

          -  Clinical symptoms of pulmonary embolism

          -  Life expectancy less than 3 months

          -  Patient unable to adhere to protocol or follow-up visits and contacts

          -  Participants under legal guardianship or incapacitation

          -  Patient already enrolled in a deep vein thrombosis (DVT) diagnostic research
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antoine Elias, MD</last_name>
    <role>Study Director</role>
    <affiliation>Centre Hospitalier Intercommunal Toulon La Seyne sur Mer</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anais Maugard</last_name>
    <phone>04 94 14 55 29</phone>
    <phone_ext>+33</phone_ext>
    <email>anais.maugardlandre@ch-toulon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre Hospitalier de Vichy</name>
      <address>
        <city>Vichy</city>
        <state>Allier</state>
        <zip>03200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Fabrice Abbadie, MD</last_name>
      <phone>04 70 97 34 52</phone>
      <phone_ext>+33</phone_ext>
      <email>fabrice.abbadie@ch-vichy.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Nice</name>
      <address>
        <city>Nice</city>
        <state>Alpes-Maritimes</state>
        <zip>06001</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pascal GIORDANA, MD</last_name>
      <phone>04 92 03 77 16</phone>
      <phone_ext>+33</phone_ext>
      <email>giordana.pascal@wanadoo.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Carcassonne</name>
      <address>
        <city>Carcassonne</city>
        <state>Aude</state>
        <zip>1060</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Géraldine Paoli-Cazanave, MD</last_name>
      <phone>04 68 24 23 11</phone>
      <phone_ext>+33</phone_ext>
      <email>geraldine.paoli-cazanave@ch-carcassonne.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre d'angiologie</name>
      <address>
        <city>Carcassonne</city>
        <state>Aude</state>
        <zip>11000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alain Cazanave, MD</last_name>
      <phone>06 16 04 15 07</phone>
      <phone_ext>+33</phone_ext>
      <email>acazanave@yahoo.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>APHM La Timone</name>
      <address>
        <city>Marseille</city>
        <state>Bouches Du Rhône</state>
        <zip>13385</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gabrielle Sarlon-Bartoli, MD</last_name>
      <phone>06 16 33 39 17</phone>
      <phone_ext>+33</phone_ext>
      <email>gabrielle.sarlon@ap-hm.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cabinet libéral De Mari</name>
      <address>
        <city>Ajaccio</city>
        <state>Corse Du Sud</state>
        <zip>20090</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Céline De Mari Lovichi, MD</last_name>
      <phone>06 29 55 52 94</phone>
      <phone_ext>+33</phone_ext>
      <email>dr.celine.demari@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cabinet libéral Secondi</name>
      <address>
        <city>Ajaccio</city>
        <state>Corse Du Sud</state>
        <zip>20090</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-François Secondi, MD</last_name>
      <phone>06 75 69 22 97</phone>
      <phone_ext>+33</phone_ext>
      <email>dr.jf.secondi@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire Bocage</name>
      <address>
        <city>Dijon</city>
        <state>Cote d'Or</state>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Béatrice Terriat, MD</last_name>
      <phone>03 80 29 34 09</phone>
      <phone_ext>+33</phone_ext>
      <email>beatrice.terriat@chu-dijon.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire François Mitterrand</name>
      <address>
        <city>Dijon</city>
        <state>Côte d'Or</state>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nicolas Falvo, MD</last_name>
      <phone>06 78 72 81 24</phone>
      <phone_ext>+33</phone_ext>
      <email>nicolas.falvo@chu-dijon.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre hospitalier Universitaire Cavale Blanche</name>
      <address>
        <city>Brest</city>
        <state>Finistère</state>
        <zip>29609</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Francis Couturaud, MD</last_name>
      <phone>02 98 34 73 47</phone>
      <phone_ext>+33</phone_ext>
      <email>francis.couturaud@chu-brest.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Nîmes</name>
      <address>
        <city>Nîmes</city>
        <state>Gard</state>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Antonia Perez-Martin, MD</last_name>
      <phone>04 66 68 33 13</phone>
      <phone_ext>+33</phone_ext>
      <email>antonia.perez.martin@chu-nimes.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier d'Auch</name>
      <address>
        <city>Auch</city>
        <state>Gers</state>
        <zip>32000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hélène Paradis, MD</last_name>
      <phone>05 62 61 31 47</phone>
      <phone_ext>+33</phone_ext>
      <email>h.paradis@ch-auch.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Saint André</name>
      <address>
        <city>Bordeaux</city>
        <state>Gironde</state>
        <zip>33075</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joel Constans, MD</last_name>
      <phone>05 56 79 58</phone>
      <phone_ext>+33</phone_ext>
      <email>joel.constans@chu-bordeaux.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre de medicine vasculaire interventionnel</name>
      <address>
        <city>Langon</city>
        <state>Gironde</state>
        <zip>33210</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antoine Diard, MD</last_name>
      <phone>05 56 40 28 61</phone>
      <phone_ext>+33</phone_ext>
      <email>antoine.diard@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cabinet libéral Bonavita</name>
      <address>
        <city>Bastia</city>
        <state>Haute-Corse</state>
        <zip>20200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paola Bonavita, MD</last_name>
      <phone>04 95 38 41 14</phone>
      <phone_ext>+33</phone_ext>
      <email>paola.bonavita@hotmail.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire Rangueil</name>
      <address>
        <city>Toulouse</city>
        <state>Haute-Garonne</state>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>François-Xavier Labepie, MD</last_name>
      <phone>05 61 32 30 35</phone>
      <phone_ext>+33</phone_ext>
      <email>labepie.fx@chu-toulouse.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinique Rive Gauche</name>
      <address>
        <city>Toulouse</city>
        <state>Haute-Garonne</state>
        <zip>31076</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Anne VINEL, MD</last_name>
      <phone>05 61 77 33 14</phone>
      <phone_ext>+33</phone_ext>
      <email>vinelanne@orange.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cabinet libéral Wagner</name>
      <address>
        <city>Lourdes</city>
        <state>Hautes-Pyrénées</state>
        <zip>65100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jacqueline WAGNER, MD</last_name>
      <phone>05 62 94 99 27</phone>
      <phone_ext>+33</phone_ext>
      <email>jline.wagner@free.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cabinet libéral Esteve</name>
      <address>
        <city>Tarbes</city>
        <state>Hautes-Pyrénées</state>
        <zip>65000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Serge Esteve, MD</last_name>
      <phone>06 77 55 53 39</phone>
      <phone_ext>+33</phone_ext>
      <email>esteve.serge@wanadoo.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Montpellier</name>
      <address>
        <city>Montpellier</city>
        <state>Hérault</state>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Isabelle QUERE, MD</last_name>
      <phone>04 67 33 70 25</phone>
      <phone_ext>+33</phone_ext>
      <email>i-quere@chu-montpellier.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Européen Georges Pompidou</name>
      <address>
        <city>Paris</city>
        <state>Ile-de-France</state>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Emmanuel Messas, MD</last_name>
      <phone>01 56 09 29 83</phone>
      <phone_ext>+33</phone_ext>
      <email>emmanuel.messas@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre d'explorations vasculaires</name>
      <address>
        <city>Paris</city>
        <state>Ile-de-France</state>
        <zip>75116</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michel Dadon, MD</last_name>
      <phone>01 45 00 00 07</phone>
      <phone_ext>+33</phone_ext>
      <email>cev16@wanadoo.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Grenoble</name>
      <address>
        <city>Grenoble</city>
        <state>Isère</state>
        <zip>38700</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gilles Pernod, MD</last_name>
      <phone>04 76 76 57 17</phone>
      <phone_ext>+33</phone_ext>
      <email>gpernod@chu-grenoble.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire Nord</name>
      <address>
        <city>Saint-Étienne</city>
        <state>Loire</state>
        <zip>42055</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Claire Le Hello, MD</last_name>
      <phone>04 77 82 83 23</phone>
      <phone_ext>+33</phone_ext>
      <email>claire.lehello@chu-st-etienne.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire d'Angers</name>
      <address>
        <city>Angers</city>
        <state>Maine-et-Loire</state>
        <zip>49933</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Samir Henni, MD</last_name>
      <phone>02 41 35 46 17</phone>
      <phone_ext>+33</phone_ext>
      <email>Samir.Henni@chu-angers.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Nancy</name>
      <address>
        <city>Nancy</city>
        <state>Meurthe Et Moselle</state>
        <zip>54511</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Denis Wahl, MD</last_name>
      <phone>03 83 15 36 14</phone>
      <phone_ext>+33</phone_ext>
      <email>d.wahl@chu-nancy.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Espace Artois Santé</name>
      <address>
        <city>Arras</city>
        <state>Pas-de-Calais</state>
        <zip>62000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sandro Aquilanti, MD</last_name>
      <phone>03 21 71 36 66</phone>
      <phone_ext>+33</phone_ext>
      <email>saquilanti@nordnet.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Clermont-Ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <state>Puy-de-Dôme</state>
        <zip>63000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nicolas Dublanchet, MD</last_name>
      <phone>04 73 75 45 49</phone>
      <phone_ext>+33</phone_ext>
      <email>ndublanchet@chu-clermontferrand.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire d'Amiens</name>
      <address>
        <city>Amiens</city>
        <state>Somme</state>
        <zip>80054</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marie-Antoinette Sevestre, MD</last_name>
      <phone>03 22 08 73 06</phone>
      <phone_ext>+33</phone_ext>
      <email>sevestre.marie-antoinette@chu-amiens.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Brignoles</name>
      <address>
        <city>Brignoles</city>
        <state>Var</state>
        <zip>83170</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anaïs CORNE, MD</last_name>
      <phone>06 26 90 63 82</phone>
      <phone_ext>+33</phone_ext>
      <email>anaiscorne@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cabinet libéral Richard</name>
      <address>
        <city>Sanary-sur-Mer</city>
        <state>Var</state>
        <zip>83110</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Colin RICHARD, MD</last_name>
      <phone>06 12 85 44 65</phone>
      <phone_ext>+33</phone_ext>
      <email>colin.richard29@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cabinet libéral Ben Sedrine</name>
      <address>
        <city>Six-Fours-les-Plages</city>
        <state>Var</state>
        <zip>83140</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sophia Ben Sedrine, MD</last_name>
      <phone>04 94 07 33 80</phone>
      <phone_ext>+33</phone_ext>
      <email>sophia.ange@wanadoo.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cabinet libéral Riviere</name>
      <address>
        <city>Six-Fours-les-Plages</city>
        <state>Var</state>
        <zip>83140</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Caroline Rivière, MD</last_name>
      <phone>04 94 07 33 80</phone>
      <phone_ext>+33</phone_ext>
      <email>dr.riviere.caroline@orange.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cabinet libéral Zimmermann</name>
      <address>
        <city>Six-Fours-les-Plages</city>
        <state>Var</state>
        <zip>83140</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emilie Zimmermann, MD</last_name>
      <phone>06 11 51 38 17</phone>
      <phone_ext>+33</phone_ext>
      <email>zimmermannemilie@yahoo.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Intercommunal Toulon La Seyne sur Mer</name>
      <address>
        <city>Toulon</city>
        <state>Var</state>
        <zip>83056</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antoine Elias, MD</last_name>
      <phone>04 94 14 58 09</phone>
      <phone_ext>+33</phone_ext>
      <email>antoine.elias@free.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Ageno W, Squizzato A, Wells PS, Büller HR, Johnson G. The diagnosis of symptomatic recurrent pulmonary embolism and deep vein thrombosis: guidance from the SSC of the ISTH. J Thromb Haemost. 2013 Aug;11(8):1597-602. doi: 10.1111/jth.12301.</citation>
    <PMID>23682905</PMID>
  </reference>
  <reference>
    <citation>Aguilar C, del Villar V. Combined D-dimer and clinical probability are useful for exclusion of recurrent deep venous thrombosis. Am J Hematol. 2007 Jan;82(1):41-4.</citation>
    <PMID>16947316</PMID>
  </reference>
  <reference>
    <citation>Bates SM, Jaeschke R, Stevens SM, Goodacre S, Wells PS, Stevenson MD, Kearon C, Schunemann HJ, Crowther M, Pauker SG, Makdissi R, Guyatt GH. Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb;141(2 Suppl):e351S-e418S. doi: 10.1378/chest.11-2299.</citation>
    <PMID>22315267</PMID>
  </reference>
  <reference>
    <citation>Fraser DG, Moody AR, Morgan PS, Martel AL, Davidson I. Diagnosis of lower-limb deep venous thrombosis: a prospective blinded study of magnetic resonance direct thrombus imaging. Ann Intern Med. 2002 Jan 15;136(2):89-98.</citation>
    <PMID>11790060</PMID>
  </reference>
  <reference>
    <citation>Geersing GJ, Zuithoff NP, Kearon C, Anderson DR, Ten Cate-Hoek AJ, Elf JL, Bates SM, Hoes AW, Kraaijenhagen RA, Oudega R, Schutgens RE, Stevens SM, Woller SC, Wells PS, Moons KG. Exclusion of deep vein thrombosis using the Wells rule in clinically important subgroups: individual patient data meta-analysis. BMJ. 2014 Mar 10;348:g1340. doi: 10.1136/bmj.g1340. Review.</citation>
    <PMID>24615063</PMID>
  </reference>
  <reference>
    <citation>Goodacre S, Sampson F, Thomas S, van Beek E, Sutton A. Systematic review and meta-analysis of the diagnostic accuracy of ultrasonography for deep vein thrombosis. BMC Med Imaging. 2005 Oct 3;5:6.</citation>
    <PMID>16202135</PMID>
  </reference>
  <reference>
    <citation>Hamadah A, Alwasaidi T, LE Gal G, Carrier M, Wells PS, Scarvelis D, Gonsalves C, Forgie M, Kovacs MJ, Rodger MA. Baseline imaging after therapy for unprovoked venous thromboembolism: a randomized controlled comparison of baseline imaging for diagnosis of suspected recurrence. J Thromb Haemost. 2011 Dec;9(12):2406-10. doi: 10.1111/j.1538-7836.2011.04533.x.</citation>
    <PMID>21985174</PMID>
  </reference>
  <reference>
    <citation>Hassen S, Barrellier MT, Seinturier C, Bosson JL, Genty C, Long A, Pernod G. High percentage of non-diagnostic compression ultrasonography results and the diagnosis of ipsilateral recurrent proximal deep vein thrombosis: a rebuttal. J Thromb Haemost. 2011 Feb;9(2):414-6; author reply 417-8. doi: 10.1111/j.1538-7836.2010.04137.x.</citation>
    <PMID>21070594</PMID>
  </reference>
  <reference>
    <citation>Heijboer H, Jongbloets LM, Büller HR, Lensing AW, ten Cate JW. Clinical utility of real-time compression ultrasonography for diagnostic management of patients with recurrent venous thrombosis. Acta Radiol. 1992 Jul;33(4):297-300.</citation>
    <PMID>1633039</PMID>
  </reference>
  <reference>
    <citation>Hull RD, Carter CJ, Jay RM, Ockelford PA, Hirsch J, Turpie AG, Zielinsky A, Gent M, Powers PJ. The diagnosis of acute, recurrent, deep-vein thrombosis: a diagnostic challenge. Circulation. 1983 Apr;67(4):901-6.</citation>
    <PMID>6825247</PMID>
  </reference>
  <reference>
    <citation>Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, Huisman M, King CS, Morris TA, Sood N, Stevens SM, Vintch JRE, Wells P, Woller SC, Moores L. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest. 2016 Feb;149(2):315-352. doi: 10.1016/j.chest.2015.11.026. Epub 2016 Jan 7. Erratum in: Chest. 2016 Oct;150(4):988.</citation>
    <PMID>26867832</PMID>
  </reference>
  <reference>
    <citation>Le Gal G, Righini M, Roy PM, Sanchez O, Aujesky D, Perrier A, Bounameaux H. Value of D-dimer testing for the exclusion of pulmonary embolism in patients with previous venous thromboembolism. Arch Intern Med. 2006 Jan 23;166(2):176-80.</citation>
    <PMID>16432085</PMID>
  </reference>
  <reference>
    <citation>Le Gal G, Kovacs MJ, Carrier M, Do K, Kahn SR, Wells PS, Anderson DA, Chagnon I, Solymoss S, Crowther M, Righini M, Perrier A, White RH, Vickars L, Rodger M. Validation of a diagnostic approach to exclude recurrent venous thromboembolism. J Thromb Haemost. 2009 May;7(5):752-9. doi: 10.1111/j.1538-7836.2009.03324.x. Epub 2009 Feb 18.</citation>
    <PMID>19228281</PMID>
  </reference>
  <reference>
    <citation>Linkins LA, Stretton R, Probyn L, Kearon C. Interobserver agreement on ultrasound measurements of residual vein diameter, thrombus echogenicity and Doppler venous flow in patients with previous venous thrombosis. Thromb Res. 2006;117(3):241-7. Epub 2005 Mar 21.</citation>
    <PMID>16378830</PMID>
  </reference>
  <reference>
    <citation>Prandoni P, Cogo A, Bernardi E, Villalta S, Polistena P, Simioni P, Noventa F, Benedetti L, Girolami A. A simple ultrasound approach for detection of recurrent proximal-vein thrombosis. Circulation. 1993 Oct;88(4 Pt 1):1730-5.</citation>
    <PMID>8403319</PMID>
  </reference>
  <reference>
    <citation>Prandoni P, Lensing AW, Bernardi E, Villalta S, Bagatella P, Girolami A; DERECUS Investigators Group. The diagnostic value of compression ultrasonography in patients with suspected recurrent deep vein thrombosis. Thromb Haemost. 2002 Sep;88(3):402-6.</citation>
    <PMID>12353067</PMID>
  </reference>
  <reference>
    <citation>Prandoni P, Tormene D, Dalla Valle F, Concolato A, Pesavento R. D-dimer as an adjunct to compression ultrasonography in patients with suspected recurrent deep vein thrombosis. J Thromb Haemost. 2007 May;5(5):1076-7. Epub 2007 Mar 15.</citation>
    <PMID>17367489</PMID>
  </reference>
  <reference>
    <citation>Rathbun SW, Whitsett TL, Raskob GE. Negative D-dimer result to exclude recurrent deep venous thrombosis: a management trial. Ann Intern Med. 2004 Dec 7;141(11):839-45.</citation>
    <PMID>15583225</PMID>
  </reference>
  <reference>
    <citation>Schulman S, Granqvist S, Holmström M, Carlsson A, Lindmarker P, Nicol P, Eklund SG, Nordlander S, Lärfars G, Leijd B, Linder O, Loogna E. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group. N Engl J Med. 1997 Feb 6;336(6):393-8.</citation>
    <PMID>9010144</PMID>
  </reference>
  <reference>
    <citation>Tan M, Velthuis SI, Westerbeek RE, VAN Rooden CJ, VAN DER Meer FJ, Huisman MV. High percentage of non-diagnostic compression ultrasonography results and the diagnosis of ipsilateral recurrent proximal deep vein thrombosis. J Thromb Haemost. 2010 Apr;8(4):848-50. doi: 10.1111/j.1538-7836.2010.03758.x.</citation>
    <PMID>20398187</PMID>
  </reference>
  <reference>
    <citation>Tan M, Bornais C, Rodger M. Interobserver reliability of compression ultrasound for residual thrombosis after first unprovoked deep vein thrombosis. J Thromb Haemost. 2012 Sep;10(9):1775-82. doi: 10.1111/j.1538-7836.2012.04827.x.</citation>
    <PMID>22726359</PMID>
  </reference>
  <reference>
    <citation>Tan M, Mol GC, van Rooden CJ, Klok FA, Westerbeek RE, Iglesias Del Sol A, van de Ree MA, de Roos A, Huisman MV. Magnetic resonance direct thrombus imaging differentiates acute recurrent ipsilateral deep vein thrombosis from residual thrombosis. Blood. 2014 Jul 24;124(4):623-7. doi: 10.1182/blood-2014-04-566380. Epub 2014 Jun 13.</citation>
    <PMID>24928859</PMID>
  </reference>
  <reference>
    <citation>van der Hulle T, Tan M, den Exter PL, van Roosmalen MJ, van der Meer FJ, Eikenboom J, Huisman MV, Klok FA. Recurrence risk after anticoagulant treatment of limited duration for late, second venous thromboembolism. Haematologica. 2015 Feb;100(2):188-93. doi: 10.3324/haematol.2014.112896. Epub 2014 Sep 26.</citation>
    <PMID>25261098</PMID>
  </reference>
  <reference>
    <citation>Westerbeek RE, Van Rooden CJ, Tan M, Van Gils AP, Kok S, De Bats MJ, De Roos A, Huisman MV. Magnetic resonance direct thrombus imaging of the evolution of acute deep vein thrombosis of the leg. J Thromb Haemost. 2008 Jul;6(7):1087-92. doi: 10.1111/j.1538-7836.2008.02986.x. Epub 2008 Jul 1.</citation>
    <PMID>18433464</PMID>
  </reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 8, 2019</study_first_submitted>
  <study_first_submitted_qc>March 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 11, 2019</study_first_posted>
  <last_update_submitted>March 10, 2020</last_update_submitted>
  <last_update_submitted_qc>March 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Deep vein thrombosis</keyword>
  <keyword>Recurrence</keyword>
  <keyword>Diagnostic strategy</keyword>
  <keyword>Colour doppler ultrasound</keyword>
  <keyword>D-dimer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thrombosis</mesh_term>
    <mesh_term>Venous Thrombosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrin fragment D</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

